Takeda shares drop after report on $6 bln jury award over Actos
TOKYO, April 8
TOKYO, April 8 (Reuters) - Shares in Takeda Pharmaceutical Co Ltd were down nearly 6 percent on Tuesday morning after Bloomberg news reported that a U.S. jury ordered it to pay $6 billion in punitive damages in a case claiming it hid cancer risks of its Actos diabetes drug.
Takeda representatives could not immediately be reached for comment.
Takeda's shares were down 5.7 percent at midday at 4,545 yen, after falling as far as 4,483, a six-month low.
(Reporting by Ritsuko Shimizu and Edmund Klamann; Editing by Dominic Lau)
- French warplanes search Mali desert for crashed Air Algerie plane |
- At least 15 killed by shelling of Gaza school; toll exceeds 760 |
- Exclusive: Ukraine rebel commander acknowledges fighters had BUK missile
- U.S. House panel votes to authorize lawsuit against Obama
- Lawyers call for outside probe of 'bungled' Arizona execution |